Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
Ixabepilone (sold as Ixempra) is an intravenous chemotherapy medication used to treat advanced or metastatic breast cancer. It works as a microtubule inhibitor to kill cancer cells, typically given once every three weeks either alone or combined with capecitabine when other treatments stop working
Ixabepilone (sold as Ixempra) is an intravenous chemotherapy medication used to treat advanced or metastatic breast cancer. It works as a microtubule inhibitor to kill cancer cells, typically given once every three weeks either alone or combined with capecitabine when other treatments stop working